As a result of the entry into force of Regulation (EU) 2018/1532 concerning the non-renewal of diquat approval, ANSES has withdrawn 15 authorisations and 4 parallel […]
On 28 May 2019, Anses opinion on endocrine-disrupting properties of the active substance epoxiconazole was published and the withdrawal of marketing authorisations of epoxiconazole-based products was […]
Anses has published a note detailing the requirements for grouping article 43 renewal applications in accordance with Regulation (EC) No.1107/2009. It is noted that the applicant […]
In March 2019, the European Commission (EC) mandated EFSA for a review of its guidance on the Risk Assessment of Plant Protection Products on Bees (EFSA […]